Laboratory of Biomedical Embryology, Department of Health, Animal Science and Food Safety and Center for Stem Cell Research, Università degli Studi di Milano, Milan, Italy.
Technion- Israel Institute of Technology, Haifa, Israel.
Methods Mol Biol. 2021;2273:139-149. doi: 10.1007/978-1-0716-1246-0_9.
Ovarian failure is the most common cause of infertility and affects about 1% of young women. One innovative strategy to restore ovarian function may be represented by the development of a bioprosthetic ovary, obtained through the combination of tissue engineering and regenerative medicine.We here describe the two main steps required for bioengineering the ovary and for its ex vivo functional reassembling. The first step aims at producing a 3D bioscaffold, which mimics the natural ovarian milieu in vitro. This is obtained with a whole organ decellularization technique that allows the maintenance of microarchitecture and biological signals of the original tissue. The second step involves the use of magnetic activated cell sorting (MACS) to isolate purified female germline stem cells (FGSCs). These cells are able to differentiate in ovarian adult mature cells, when subjected to specific stimuli, and can be used them to repopulate ovarian decellularized bioscaffolds. The combination of the two techniques represents a powerful tool for in vitro recreation of a bioengineered ovary that may constitute a promising solution for hormone and fertility function restoring. In addition, the procedures here described allow for the creation of a suitable 3D platform with useful applications both in toxicological and transplantation studies.
卵巢衰竭是导致不孕的最常见原因,约影响 1%的年轻女性。恢复卵巢功能的一种创新策略可能是通过组织工程和再生医学的结合来开发生物假体卵巢。我们在这里描述了生物工程卵巢及其体外功能重新组装所需的两个主要步骤。第一步旨在产生 3D 生物支架,该支架在体外模拟自然卵巢环境。这是通过整个器官去细胞化技术实现的,该技术可保持原始组织的微结构和生物信号。第二步涉及使用磁性激活细胞分选 (MACS) 来分离纯化的雌性生殖干细胞 (FGSCs)。这些细胞在受到特定刺激时可以分化为卵巢成年成熟细胞,并可用于重新填充卵巢去细胞化生物支架。这两种技术的结合代表了体外重现生物工程卵巢的强大工具,可能为恢复激素和生育功能提供有前途的解决方案。此外,这里描述的程序允许创建具有有用应用的合适 3D 平台,无论是在毒理学还是移植研究中。